Eiko LifeSciences Limited (BOM:540204)

Eiko LifeSciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	725	674	717	636	403	303
Market Cap Growth	-9.63%	-5.99%	12.74%	57.59%	33.32%	680.30%
Enterprise Value	660	647	676	680	398	297
Last Close Price	49.86	52.33	51.70	66.24	42.03	68.64
PE Ratio	19.55	31.99	95.35	82.68	57.15	49.25
PS Ratio	1.76	1.79	2.57	3.47	1.59	2.52
PB Ratio	1.22	1.18	1.41	2.16	1.41	2.42
P/TBV Ratio	1.23	1.19	1.41	2.16	1.41	2.42
P/FCF Ratio	112.75	-	-	15.89	-	-
P/OCF Ratio	6.63	23.04	-	15.05	-	-
EV/Sales Ratio	1.60	1.72	2.42	3.71	1.57	2.48
EV/EBITDA Ratio	12.13	23.43	41.90	71.21	30.27	51.85
EV/EBIT Ratio	14.68	31.96	71.12	211.29	52.86	58.08
EV/FCF Ratio	102.72	-	-	17.00	-	-
Debt / Equity Ratio	0.02	0.05	-	0.00	0.16	0.15
Debt / EBITDA Ratio	0.19	1.00	-	0.06	3.52	3.18
Debt / FCF Ratio	1.57	-	-	0.01	-	-
Asset Turnover	0.69	0.63	0.67	0.56	0.99	0.84
Inventory Turnover	13.62	7.16	11.84	5.06	8.19	6.49
Quick Ratio	6.69	3.60	17.60	6.44	0.80	2.62
Current Ratio	8.40	5.25	20.56	7.76	2.24	2.70
Return on Equity (ROE)	7.35%	4.31%	1.88%	2.65%	3.43%	9.01%
Return on Assets (ROA)	4.50%	2.13%	1.42%	0.61%	1.83%	2.23%
Return on Invested Capital (ROIC)	4.80%	2.29%	1.48%	0.64%	1.98%	3.75%
Return on Capital Employed (ROCE)	7.00%	3.40%	1.90%	1.10%	2.60%	4.00%
Earnings Yield	4.75%	3.13%	1.05%	1.21%	1.75%	2.03%
FCF Yield	0.89%	-10.94%	-10.36%	6.29%	-19.54%	-2.73%
Buyback Yield / Dilution	-15.43%	-26.37%	-5.41%	-25.30%	-104.48%	-
Total Shareholder Return	-15.43%	-26.37%	-5.41%	-25.30%	-104.48%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.